3SBio Inc.
3SBio Inc. Applies for SFDA Registrational Trial for Feraheme
Published in Blood Weekly, January 21st, 2010
3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use. Feraheme is an intravenous iron therapy that 3SBio licensed from AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for development in China for the treatment of iron deficiency anemia in adult patients with chronic kidney disease ("CKD").
Feraheme was approved on June 30, 2009 by the U.S. Food and Drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-01-21)
More Articles from Blood Weekly
- Wiley-Blackwell
Liver donations from living donors increase 42 percent after educational intervention - Wiley-Blackwell
Liver stiffness measurements identify patients with rapid or slow fibrosis - Abdominal Aortic Aneurysm
Research conducted at J. Elkafsi and co-authors has provided new information about abdominal aortic aneurysm - American Academy of Orthopaedic Surgeons
New Study Finds Low Mortality Risk Following Knee and Hip Replacement - Anemia
Data on anemia detailed by H. Yoshida and co-authors - Anemia
Research on anemia published by S.W. Wang et al - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
